These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

578 related items for PubMed ID: 25946973

  • 1. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [Abstract] [Full Text] [Related]

  • 2. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
    Hu F, Yuan W, Wang X, Sheng Z, Yuan Y, Qin C, He C, Xu T.
    Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
    [Abstract] [Full Text] [Related]

  • 3. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
    Zhang H, Nan X, Li X, Chen Y, Zhang J, Sun L, Han W, Li T.
    Biochem Biophys Res Commun; 2014 May 02; 447(2):304-10. PubMed ID: 24721428
    [Abstract] [Full Text] [Related]

  • 4. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
    Lu M, Huang Y, Sun W, Li P, Li L, Li L.
    Int J Oncol; 2018 Feb 02; 52(2):589-598. PubMed ID: 29345297
    [Abstract] [Full Text] [Related]

  • 5. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z, Xie N, Hu J, Yu P, Wang C, Hu X, Han X, Hou J, Huang H, Liu X.
    Oncotarget; 2017 Mar 28; 8(13):21954-21973. PubMed ID: 28423539
    [Abstract] [Full Text] [Related]

  • 6. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY, Liew PL, Chen CL, Lin YH, Fang CL, Chen WY.
    Anticancer Res; 2017 Apr 28; 37(4):1891-1899. PubMed ID: 28373457
    [Abstract] [Full Text] [Related]

  • 7. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W, Song X, Yang X, Ma L, Zhu J, He M, Wang Z, Wu Y.
    PLoS One; 2014 Apr 28; 9(7):e101931. PubMed ID: 24999732
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K.
    Cancer Res; 2016 Jun 01; 76(11):3265-76. PubMed ID: 27197151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC, Chen PN, Peng CY, Yu CH, Chou MY.
    Oncotarget; 2016 Apr 12; 7(15):20180-92. PubMed ID: 26933999
    [Abstract] [Full Text] [Related]

  • 16. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X, Li YF, Chen GD, Ou DP, Qiu XX, Zuo CH, Yang LY.
    Oncotarget; 2015 Dec 01; 6(38):40622-41. PubMed ID: 26536663
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.